Thomas Philip, PMP®, is a seasoned professional in clinical development with extensive experience in leading global studies across diverse therapeutic areas. Currently serving as Director of Global Clinical Development Programs at ICON plc, Thomas manages clinical studies for Multiple Myeloma and Bladder Cancer for Johnson & Johnson Innovative Medicine. Previous roles include Project Leader at IQVIA, focusing on Cardiovascular and Kidney Rare Diseases, and Project Lead at Sanofi Pasteur, where Thomas consulted on global R&D portfolio planning and digital transformation initiatives. Earlier positions include Senior Manager at Cipla, Clinical Program Manager at Dr. Reddy's Laboratories, and Clinical Project Manager at Tata Consultancy Services. Thomas holds a Master of Science in Clinical Research from Cranfield University and a Bachelor of Science with Honors in Chemistry from St. Xavier's College.
This person is not in any teams
This person is not in any offices